Trial
NCT06188208
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Vividion Therapeutics, Inc.
Collaborators
—
Condition
Advanced Solid Tumors
Intervention
VVD-130850
Why stopped
The study has ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-12